Hitting the bull's eye: Novel directed cancer therapy through helicase-targeted Synthetic lethality

Journal of Cellular Biochemistry

Volumn 106, Issue 5, 2009, Pages 758-763

  Aggarwal, Monika ^a   Brosh Jr , Robert M ^a,b  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Anti cancer drug; Cancer therapy; DNA repair; Helicase; Synthetic lethality

Indexed keywords

HELICASE;

CANCER THERAPY; DNA DAMAGE; DNA REPAIR; ENZYME INHIBITION; GENE INTERACTION; LETHALITY; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; DNA HELICASES; DNA REPAIR; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS;

EUKARYOTA;

EID: 65349085023     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22048     Document Type: Review

References (52)

1. Adhikari S, Choudhury S, Mitra PS, Dubash JJ, Sajankila SP, Roy R. 2008. Targeting base excision repair for chemosensitization. Anticancer Agents Med Chem 8:351-357.
2. Allan JM, Travis LB. 2005. Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer 5:943-955.
3. Barber LJ, Youds JL, Ward JD, McIlwraith MJ, O'Neil NJ, Pet al.corin MI, Martin JS, Collis SJ, Cantor SB, Auclair M, Tissenbaum H, West SC, Rose AM
4. Boulton SJ. 2008. RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135:261-271.
5. Bernstein NK, Karimi-Busheri F, Rasouli-Nia A, Mani R, Dianov G, Glover JN, Weinfeld M. 2008. Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors. Anticancer Agents Med Chem 8:358-367.
6. Boddy MN, Lopez-Girona A, Shanahan P, Interthal H, Heyer WD, Russell P. 2000. Damage tolerance protein Mus81 associates with the FHA1 domain of checkpoint kinase Cds1. Mol Cell Biol 20:8758-8766.
7. Brosh RM, Jr. 2008. DNA repair as a target for anti-cancer therapy. Anticancer Agents Med Chem 8:350.
8. Brosh RM, Jr., von Kobbe C, Sommers JA, Karmakar P, Opresko PL, Piotrowski J, Dianova I, Dianov GL, Bohr VA. 2001. Werner syndrome protein interacts with human Flap Endonuclease 1 and stimulates its cleavage activity. EMBO J 20:5791-5801.
9. Brosh RM, Jr., Driscoll HC, Dianov GL, Sommers JA. 2002. Biochemical characterization of the WRN-FEN-1 functional interaction. Biochemistry 41:12204-12216.
10. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, Helleday T. 2005. Specific killing of BRCA2-deficient tumours with inhibitors of poly (ADP-ribose) polymerase. Nature 434:913- 917.
11. Budd ME, Tong AH, Polaczek P, Peng X, Boone C, Campbell JL. 2005. A network of multi-tasking proteins at the DNA replication fork preserves genome stability. PLoS Genet 1:e61.
12. Casorelli I, Russo MT, Bignami M. 2008. Role of mismatch repair and MGMT in response to anticancer therapies. Anticancer Agents Med Chem 8:368- 380.
13. Cogoni C, Macino G. 1999. Posttranscriptional gene silencing in Neurospora by a RecQ DNA helicase. Science 286:2342-2344.
14. Dexheimer TS, Antony S, Marchand C, Pommier Y. 2008. Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy. Anticancer Agents Med Chem 8:381-389.
15. Doherty KM, Sharma S, Uzdilla L, Wilson TM, Cui S, Vindigni A, Brosh RM, Jr. 2005. RECQ1 helicase interacts with human mismatch repair factors that regulate gentic recombination. J Biol Chem 280:28025-28094.
16. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, Ashworth A. 2005. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434:917-921.
17. Gangloff S, Soustelle C, Fabre F. 2000. Homologous recombination is responsible for cell death in the absence of the Sgs1 and Srs2 helicases. Nat Genet 25:192-194.
18. Gupta R, Brosh RM, Jr. 2007. DNA repair helicases as targets for anti-cancer therapy. Curr Med Chem 14:503-517.
19. Gupta R, Brosh RM, Jr. 2008. Helicases as prospective targets for anti-cancer therapy. Anticancer Agents Med Chem 8:390-401.
20. Helleday T. 2008. Amplifying tumour-specific replication lesions by DNA repair inhibitors-A new era in targeted cancer therapy. Eur J Cancer 44:921 - 927.
21. Helleday T, Petermann E, Lundin C, Hodgson B, Sharma RA. 2008. DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 8:193- 204.
22. Hirano S, Yamamoto K, Ishiai M, Yamazoe M, Seki M, Matsushita N, Ohzeki M, Yamashita YM, Arakawa H, Buerstedde JM, Enomoto T, Takeda S, Thompson LH, Takata M. 2005. Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM. EMBO J 24:418-427.
23. Hu Y, Lu X, Barnes E, Yan M, Lou H, Luo G. 2005. Recql5 and Blm RecQ DNA helicases have nonredundant roles in suppressing crossovers. Mol Cell Biol 25:3431-3442.
24. Kato A, Inoue H. 2006. Growth defect and mutator phenotypes of RecQ- deficient Neurospora crassa mutants separately result from homologous recombination and nonhomologous end joining during repair of DNA double-strand breaks. Genetics 172:113-125.
25. Kelley MR, Fishel ML. 2008. DNA repair proteins as molecular targets for cancer therapeutics. Anticancer Agents Med Chem 8:417-425.
26. Kohzaki M, Hatanaka A, Sonoda E, Yamazoe M, Kikuchi K, Vu TN, Szuts D, Sale JE, Shinagawa H, Watanabe M, Takeda S. 2007. Cooperative roles of vertebrate Fbh1 and Blm DNA helicases in avoidance of crossovers during recombination initiated by replication fork collapse. Mol Cell Biol 27:2812- 2820.
27. Lee SK, Johnson RE, Yu SL, Prakash L, Prakash S. 1999. Requirement of yeast SGS1 and SRS2 genes for replication and transcription. Science 286:2339- 2342.
28. Litman R, Gupta R, Brosh RM, Jr., Cantor SB. 2008. BRCA-FA pathway as a target for anti-tumor drugs. Anticancer Agents Med Chem 8:426-430.
29. Lord CJ, Ashworth A. 2008. Targeted therapy for cancer using PARP inhibitors. Curr Opin Pharmacol 8:363-369.
30. Lord CJ, McDonald S, Swift S, Turner NC, Ashworth A. 2008. A highthroughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity. DNA Repair (Amst) 7:2010-2019.
31. Maga G, Hubscher U. 2008. Repair and translesion DNA polymerases as anticancer drug targets. Anticancer Agents Med Chem 8:431-447.
32. McCabe N, Turner NC, Lord CJ, Kluzek K, Bialkowska A, Swift S, Giavara S, O'Connor MJ, Tutt AN, Zdzienicka MZ, Smith GC, Ashworth A. 2006. Deficiency in the repair of DNA damage by homologous recombination and sensitivity to Poly (ADP-ribose) polymerase inhibition. Cancer Res 66:8109-8115.
33. Morishita T, Furukawa F, Sakaguchi C, Toda T, Carr AM, Iwasaki H, Shinagawa H. 2005. Role of the Schizosaccharomyces pombe F-Box DNA helicase in processing recombination intermediates. Mol Cell Biol 25:8074- 8083.
34. Mullen JR, Kaliraman V, Ibrahim SS, Brill SJ. 2001. Requirement for three novel protein complexes in the absence of the Sgs1 DNA helicase in Saccharomyces cerevisiae. Genetics 157:103-118.
35. Nimonkar AV, Ozsoy AZ, Genschel J, Modrich P, Kowalczykowski SC. 2008. Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair. Proc Natl Acad Sci USA 105:16906-16911.
36. Ooi SL, Shoemaker DD, Boeke JD. 2003. DNA helicase gene interaction network defined using synthetic lethality analyzed by microarray. Nat Genet 35:277-286.
37. Osman F, Dixon J, Barr AR, Whitby MC. 2005. The F-Box DNA helicase Fbh1 prevents Rhp51-dependent recombination without mediator proteins. Mol Cell Biol 25:8084-8096.
38. Otsuki M, Seki M, Inoue E, Abe T, Narita Y, Yoshimura A, Tada S, Ishii Y, Enomoto T. 2007. Analyses of functional interaction between RECQL1, RECQL5, and BLM which physically interact with DNA topoisomerase IIIalpha. Biochim Biophys Acta 1782:75-81.
39. Pichierri P, Franchitto A, Rosselli F. 2004. BLM and the FANC proteins collaborate in a common pathway in response to stalled replication forks. EMBO J 23:3154-3163.
40. Pickford A, Braccini L, Macino G, Cogoni C. 2003. The QDE-3 homologue RecQ-2 co-operates with QDE-3 in DNA repair in Neurospora crassa. Curr Genet 42:220-227.
41. Powell SN, Kachnic LA. 2008. Therapeutic exploitation of tumor cell defects in homologous recombination. Anticancer Agents Med Chem 8: 448-460.
42. Sakamoto-Hojo ET, Balajee AS. 2008. Targeting poly (ADP) ribose polymerase I (PARP-1) and PARP-1 interacting proteins for cancer treatment. Anticancer Agents Med Chem 8:402-416.
43. Sharma S, Sommers JA, Driscoll HC, Uzdilla L, Wilson TM, Brosh RM, Jr. 2003a. The exonucleolytic and endonucleolytic cleavage activities of human Exonuclease 1 are stimulated by an interaction with the carboxyl-terminal region of the Werner syndrome protein. J Biol Chem 278:23487-23496.
44. Sharma S, Sommers JA, Wu L, Bohr VA, Hickson ID, Brosh RM, Jr. 2003b. Stimulation of flap endonuclease-1 by the Bloom's syndrome protein. J Biol Chem 279:9847-9856.
45. Sharma S, Otterlei M, Sommers JA, Driscoll HC, Dianov GL, Kao HI, Bambara RA, Brosh RM, Jr. 2004a. WRN helicase and FEN-1 form a complex upon replication arrest and together process branch-migrating DNA structures associated with the replication fork. Mol Biol Cell 15:734-750.
46. Sharma S, Sommers JA, Brosh RM, Jr. 2004b. In vivo function of the conserved non-catalytic domain of Werner syndrome helicase in DNA replication. Hum Mol Genet 13:2247-2261.
47. Sharma S, Sommers JA, Brosh RM, Jr. 2008. Processing of DNA replication and repair intermediates by the concerted action of RecQ helicases and Rad2 structure-specific nucleases. Protein Pept Lett 15:89-102.
48. Trowbridge K, McKim K, Brill SJ, Sekelsky J. 2007. Synthetic lethality of Drosophila in the absence of the MUS81 endonuclease and the DmBlm helicase is associated with elevated apoptosis. Genetics 176:1993-2001.
49. Wang W. 2007. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet 8:735-748.
50. Wang W, Seki M, Narita Y, Sonoda E, Takeda S, Yamada K, Masuko T, Katada T, Enomoto T. 2000. Possible association of BLM in decreasing DNA double strand breaks during DNA replication. EMBO J 19:3428-3435.
51. Wang W, Seki M, Narita Y, Nakagawa T, Yoshimura A, Otsuki M, Kawabe Y, Tada S, Yagi H, Ishii Y, Enomoto T. 2003. Functional relation among RecQ family helicases RecQL1, RecQL5, and BLM in cell growth and sister chromatid exchange formation. Mol Cell Biol 23:3527-3535.
52. Zhang R, Sengupta S, Yang Q, Linke SP, Yanaihara N, Bradsher J, Blais V, McGowan CH, Harris CC. 2005. BLM helicase facilitates Mus81 endonuclease activity in human cells. Cancer Res 65:2526-2531.